Investors.guardanthealth.com

  1. Home
  2. Investors.guardanthealth.com

Guardant Health, Inc.

WebInvestor Relations. Guardant Health is a leading precision oncology company focused on helping conquer cancer through our proprietary blood tests, vast data sets, and …

Actived: 4 days ago

URL: https://investors.guardanthealth.com/home/default.aspx

Guardant Health Reports First Quarter 2024 Financial Results and

WebRevenue growth of 31% driven by strong clinical and biopharma volume and Guardant360 ASP tailwinds Guardant Health, Inc. (Nasdaq: GH), a leading precision …

Category:  Health Go Health

Guardant Health Expands Guardant360® Portfolio With New Tests …

WebNew Guardant360 Response™ blood test predicts treatment response to immunotherapy and targeted therapy, up to eight weeks earlier than standard-of-care …

Category:  Health Go Health

Guardant Health Reports Fourth Quarter and Full Year 2022 …

WebQ4 clinical and biopharma volumes up 41% and 24% year over year Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on …

Category:  Health Go Health

Guardant Health Reports Fourth Quarter and Full Year 2023 …

WebFull year 2023 revenue growth of 25% driven by clinical volume growth of 39% Expects full year 2024 revenue to be in the range of $655 to $670 million Guardant …

Category:  Health Go Health

Guardant Health, Inc.

WebTo opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an …

Category:  Health Go Health

Guardant Health, Inc.

WebFindings from the first ‘Closing the Gap: CRC Screening Insights’ survey, released during National Colorectal Cancer Awareness Month, suggest more convenient …

Category:  Cancer Go Health

Guardant Health Appoints Craig Eagle, MD as Chief Medical Officer

WebMay 3, 2021. REDWOOD CITY, Calif.-- (BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announces the appointment of …

Category:  Health Go Health

Guardant Health, Inc.

WebREDWOOD CITY, Calif., Oct. 23, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) has initiated the ECLIPSE trial, a 10,000-patient registrational study to …

Category:  Health Go Health

Guardant Health, Inc.

WebNew research demonstrates value of epigenomic analysis and methylation sequencing with Guardant liquid biopsy portfolio across continuum of cancer care New …

Category:  Cancer Go Health

Guardant Health Reports First Quarter 2022 Financial Results

WebQ1 clinical and biopharma volumes up 47% and 45% year over year Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on …

Category:  Health Go Health

Guardant Health Reports Third Quarter 2023 Financial Results and

WebQ3 revenue increased 22% year over year driven by clinical volume growth of 35% Raises 2023 revenue guidance to $553 to 556 million Guardant Health, Inc. …

Category:  Health Go Health

Guardant Health announces positive results from pivotal ECLIPSE …

Web- The test demonstrated 83% sensitivity for the detection of colorectal cancer with specificity of 90% - Results pave the way for first potential FDA-approved and …

Category:  Cancer Go Health

Guardant Health Names Michael Bell as New Chief Financial Officer

WebGuardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, has named Michael Bell as the company’s new Chief Financial Officer (CFO) effective …

Category:  Health Go Health

Guardant Health, Inc.

WebGuardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the U.S. Food and Drug Administration’s Molecular and Clinical …

Category:  Food Go Health

Guardant Health, Inc.

WebFull year revenue growth of 25% driven by clinical volume growth of 39% Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today …

Category:  Health Go Health

Guardant Health Reports Fourth Quarter and Full Year 2020 …

Web2020 Revenue Increased 34% Over Prior Year Period Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer …

Category:  Health Go Health

Guardant Health Launches Real-World Clinical-Genomic Platform …

WebRepresents a large-scale liquid biopsy dataset of advanced cancer patients Guardant Health , Inc. (Nasdaq: GH), a leading precision oncology company, addresses …

Category:  Cancer Go Health

Guardant Health Reports Third Quarter 2022 Financial Results

WebQ3 clinical and biopharma volumes up 42% and 40% year over year Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping …

Category:  Health Go Health

Guardant Health, Inc.

WebGuardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that it has entered into a common stock purchase agreement with …

Category:  Health Go Health

Top Categories

 › Appendicitis

 › Headaches

 › Gout

 › Women's Health

 › Thyroid

 › Sleep

 › Skin

 › Sexual Health

 › Senior Health

 › Pregnancy

 › Oral Health

 › Neurology

 › Migraine

 › Mental Health

 › Men's Health

 › Menopause

 › Medications

 › Lung Conditions

 › Infectious Disease

 › HIV/AIDS

Popular Searched

 › Mental health jobs in maryland

 › Health science vic uni

 › Honor health cardiology appointment

 › Uthealth houston public health

 › Public health nursing adoptions

 › Healthy cranberry oatmeal cookies recipes

 › My south shore health

 › Public health nursing phn 2022

 › South florida mental health treatment

 › Aetna health insurance alpharetta ga

Recently Searched

 › Bmc public health abstract

 › Deakin bachelor of health science

 › Uchealth cancer center aurora co

 › Health insurance reserve minimum standards

 › Volunteer health services in florida

 › Marion health patient portal

 › Mental health workshop names

 › Learning disability physical health checks

 › Thrive behavioral health staff directory

 › Solutions alternative healthcare mansfield